175 related articles for article (PubMed ID: 32641280)
21. Human telomerase reverse transcriptase (hTERT) gene expression in thyroid carcinoma: diagnostic and prognostic role.
Asaad NY; Abd El-Wahed MM; Mohammed AG
J Egypt Natl Canc Inst; 2006 Mar; 18(1):8-16. PubMed ID: 17237847
[TBL] [Abstract][Full Text] [Related]
22. Interaction of BRAF-induced ETS factors with mutant TERT promoter in papillary thyroid cancer.
Song YS; Yoo SK; Kim HH; Jung G; Oh AR; Cha JY; Kim SJ; Cho SW; Lee KE; Seo JS; Park YJ
Endocr Relat Cancer; 2019 Jun; 26(6):629-641. PubMed ID: 30999281
[TBL] [Abstract][Full Text] [Related]
23. Preserved SCN4B expression is an independent indicator of favorable recurrence-free survival in classical papillary thyroid cancer.
Gong Y; Yang J; Wu W; Liu F; Su A; Li Z; Zhu J; Wei T
PLoS One; 2018; 13(5):e0197007. PubMed ID: 29723302
[TBL] [Abstract][Full Text] [Related]
24. Tumor Mutation Burden Predicts Relapse in Papillary Thyroid Carcinoma With Changes in Genes and Immune Microenvironment.
Guo M; Chen Z; Li Y; Li S; Shen F; Gan X; Feng J; Cai W; Liu Q; Xu B
Front Endocrinol (Lausanne); 2021; 12():674616. PubMed ID: 34248843
[TBL] [Abstract][Full Text] [Related]
25. TERT Promoter Mutations and Tumor Persistence/Recurrence in Papillary Thyroid Cancer.
Myung JK; Kwak BK; Lim JA; Lee MC; Kim MJ
Cancer Res Treat; 2016 Jul; 48(3):942-7. PubMed ID: 26727717
[TBL] [Abstract][Full Text] [Related]
26. Role of molecular markers to predict distant metastasis in papillary thyroid carcinoma: Promising value of TERT promoter mutations and insignificant role of BRAF mutations-a meta-analysis.
Vuong HG; Altibi AM; Duong UN; Ngo HT; Pham TQ; Tran HM; Oishi N; Mochizuki K; Nakazawa T; Hassell L; Katoh R; Kondo T
Tumour Biol; 2017 Oct; 39(10):1010428317713913. PubMed ID: 29037127
[TBL] [Abstract][Full Text] [Related]
27. The correlations between DNA methylation and polymorphisms in the promoter region of the human telomerase reverse transcriptase (hTERT) gene with postoperative recurrence in patients with thyroid carcinoma (TC).
Li JJ; Zheng PCJ; Wang YZ
World J Surg Oncol; 2017 Jun; 15(1):114. PubMed ID: 28587656
[TBL] [Abstract][Full Text] [Related]
28. Human telomerase reverse transcriptase (hTERT) gene expression in FNA samples from thyroid neoplasms.
Liou MJ; Chan EC; Lin JD; Liu FH; Chao TC
Cancer Lett; 2003 Mar; 191(2):223-7. PubMed ID: 12618337
[TBL] [Abstract][Full Text] [Related]
29. Prognostic prediction of patients having classical papillary thyroid carcinoma with a 4 mRNA-based risk model.
Xiang L; Zhao JH; Tang Y; Tan JW; Li LB; Gong C
Medicine (Baltimore); 2024 Jun; 103(23):e38472. PubMed ID: 38847736
[TBL] [Abstract][Full Text] [Related]
30. m
Hou J; Shan H; Zhang Y; Fan Y; Wu B
Am J Otolaryngol; 2020; 41(4):102547. PubMed ID: 32474328
[TBL] [Abstract][Full Text] [Related]
31. TERT Promoter Mutation in an Aggressive Cribriform Morular Variant of Papillary Thyroid Carcinoma.
Oh EJ; Lee S; Bae JS; Kim Y; Jeon S; Jung CK
Endocr Pathol; 2017 Mar; 28(1):49-53. PubMed ID: 27688081
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive analysis of aberrant alternative splicing related to carcinogenesis and prognosis of papillary thyroid cancer.
Zheng X; Feng L; Yin Y; Yu C; He X; Zhu J; Zhang M; Yu J; Xu M
Aging (Albany NY); 2021 Oct; 13(19):23149-23168. PubMed ID: 34628367
[TBL] [Abstract][Full Text] [Related]
33. Prediction Biomarkers Associated with Lymph Node Metastasis and Prognosis were Identified in Papillary Thyroid Carcinoma via Integrated Bioinformatics Analysis.
Gan S; Ye R; Ha Y; Xiong Y; Li R; Di X; Zou Z; Sun Y; Zhang Z
Comb Chem High Throughput Screen; 2021; 24(9):1395-1409. PubMed ID: 33155892
[TBL] [Abstract][Full Text] [Related]
34. TERT promoter mutations are associated with distant metastases in papillary thyroid carcinoma.
Gandolfi G; Ragazzi M; Frasoldati A; Piana S; Ciarrocchi A; Sancisi V
Eur J Endocrinol; 2015 Apr; 172(4):403-13. PubMed ID: 25583906
[TBL] [Abstract][Full Text] [Related]
35. A new ferroptosis-related gene model for prognostic prediction of papillary thyroid carcinoma.
Qian X; Tang J; Li L; Chen Z; Chen L; Chu Y
Bioengineered; 2021 Dec; 12(1):2341-2351. PubMed ID: 34077308
[TBL] [Abstract][Full Text] [Related]
36. Somatic Mutation Profiling of Papillary Thyroid Carcinomas by Whole-exome Sequencing and Its Relationship with Clinical Characteristics.
Qi T; Rong X; Feng Q; Sun H; Cao H; Yang Y; Feng H; Zhu L; Wang L; Du Q
Int J Med Sci; 2021; 18(12):2532-2544. PubMed ID: 34104084
[TBL] [Abstract][Full Text] [Related]
37. BRAF and TERT promoter mutations in the aggressiveness of papillary thyroid carcinoma: a study of 653 patients.
Jin L; Chen E; Dong S; Cai Y; Zhang X; Zhou Y; Zeng R; Yang F; Pan C; Liu Y; Wu W; Xing M; Zhang X; Wang O
Oncotarget; 2016 Apr; 7(14):18346-55. PubMed ID: 26943032
[TBL] [Abstract][Full Text] [Related]
38. Higher circular RNA_0015278 correlates with absence of extrathyroidal invasion, lower pathological tumor stages, and prolonged disease-free survival in papillary thyroid carcinoma patients.
Ding H; Wang X; Liu H; Na L
J Clin Lab Anal; 2021 Jul; 35(7):e23819. PubMed ID: 33969549
[TBL] [Abstract][Full Text] [Related]
39. A Set of Markers Related to Viral Infection Has a Sex-sensitive Prognostic Value in Papillary Thyroid Carcinoma.
Wan D; Yang X; Li G; Du Y; Cao J; Gao Y; Shu Z; Zhou Y; Wei X; Guo R; Zhang R; Zhang G
J Clin Endocrinol Metab; 2021 Apr; 106(5):e2334-e2346. PubMed ID: 33395461
[TBL] [Abstract][Full Text] [Related]
40. Short telomeres, telomerase reverse transcriptase gene amplification, and increased telomerase activity in the blood of familial papillary thyroid cancer patients.
Capezzone M; Cantara S; Marchisotta S; Filetti S; De Santi MM; Rossi B; Ronga G; Durante C; Pacini F
J Clin Endocrinol Metab; 2008 Oct; 93(10):3950-7. PubMed ID: 18664542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
